ZimVie Inc

ZIMV
16,82
0,17 (1,02%)
13 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:11EDGAR2Form 8-K - Current report
08/5/202422:05GLOBEZimVie Reports First Quarter 2024 Financial Results
24/4/202422:05GLOBEZimVie to Report First Quarter Financial Results on May 8,..
01/4/202414:00GLOBEZimVie Announces Closing of Sale of Spine Business
27/3/202413:00GLOBEZimVie to Participate in the 23rd Annual Needham Virtual..
11/3/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202402:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/2/202422:10EDGAR2Form 8-K - Current report
28/2/202422:05GLOBEZimVie Reports Fourth Quarter and Full Year 2023 Financial..
27/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202423:00GLOBEZimVie to Report Fourth Quarter and Full-Year 2023 Financial..
14/2/202421:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202421:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202422:05GLOBEZimVie Announces Launch of Next-Generation TSX® Implant in..
02/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:15EDGAR2Form 8-K - Current report
18/12/202314:20EDGAR2Form 8-K - Current report
18/12/202314:00GLOBEZimVie Announces Definitive Agreement to Sell Spine Business..
12/12/202314:00GLOBEZimVie Announces Compatibility Between its Vital™ Spinal..
01/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:11EDGAR2Form 8-K - Current report
01/11/202321:05GLOBEZimVie Reports Third Quarter 2023 Financial Results and..
31/10/202313:00GLOBEZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C®..
24/10/202314:00GLOBEZimVie Announces Over 2,000 Children Have Received The..
17/10/202314:30GLOBEZimVie Announces the Launch of Azure™ Multi-Platform Product..
11/10/202322:05GLOBEZimVie to Report Third Quarter 2023 Financial Results on..
10/10/202314:30GLOBEZimVie Announces the Recent Launch of Biotivity™ A/C Plus..
03/10/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202314:00GLOBEZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
17/8/202314:00GLOBEZimVie Expands Development Cooperation Agreement with..
10/8/202314:00GLOBEZimVie Announces FDA Approval for New Mobi-C® Implant
03/8/202322:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/8/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202322:10EDGAR2Form 8-K - Current report
02/8/202322:05GLOBEZimVie Reports Second Quarter 2023 Financial Results and..
12/7/202322:05GLOBEZimVie to Report Second Quarter 2023 Financial Results on..
05/7/202323:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 16,64 Min: 16,36 Max: 16,98
Chiusura: 16,65

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network